89bio
ETNB
ETNB
150 hedge funds and large institutions have $1.14B invested in 89bio in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 69 increasing their positions, 52 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 153 → 150 (-3)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
41% less call options, than puts
Call options by funds: $9.08M | Put options by funds: $15.3M
Holders
150
Holding in Top 10
3
Calls
$9.08M
Puts
$15.3M
Top Buyers
| 1 | +$42.9M | |
| 2 | +$20.9M | |
| 3 | +$16.4M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$15.7M |
| 5 |
BlackRock
New York
|
+$13.8M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$25.2M | |
| 3 | -$21.9M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$11.6M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$9.86M |